Screener
CytomX Therapeutics CTMX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from CytomX Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: CytomX Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337950
FAQ
- What is CytomX Therapeutics's operating margin?
- CytomX Therapeutics (CTMX) reported operating margin of -476.2% in Q2 2026.
- How has CytomX Therapeutics's operating margin changed year-over-year?
- CytomX Therapeutics's operating margin decreased by 1658.1% year-over-year, from 30.6% to -476.2%.
- What is the long-term trend for CytomX Therapeutics's operating margin?
- Over 5 years (2020 to 2025), CytomX Therapeutics's operating margin has grown at a -24.3% compound annual growth rate (CAGR), from -117.7% to -29.4%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about CytomX Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude